Welcome to LookChem.com Sign In|Join Free
  • or
1 beta-ribofuranosyl-4-(methylmercapto)pyrazolo(3,4-d)pyrimidine, also known as T-705 or favipiravir, is a synthetic antiviral compound that has garnered attention for its potential use in treating various infectious diseases. It operates by inhibiting the activity of viral RNA-dependent RNA polymerase, thereby disrupting viral replication and potentially exerting antiviral effects. Favipiravir is characterized by its ability to target a wide range of RNA viruses, showcasing its versatility and potential as a therapeutic agent.

60355-67-1

Post Buying Request

60355-67-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60355-67-1 Usage

Uses

Used in Pharmaceutical Industry:
Favipiravir is used as an antiviral agent for the treatment of various RNA virus infections. Its application is based on its ability to inhibit the activity of viral RNA-dependent RNA polymerase, which is crucial for viral replication. This mechanism of action has shown promise in combating a variety of RNA viruses, including influenza, Ebola, and most notably, SARS-CoV-2, the virus responsible for COVID-19. Early clinical trials have demonstrated encouraging results, and further research is being conducted to explore its potential in managing the ongoing pandemic.
Used in Research and Development:
In the field of research and development, favipiravir serves as a valuable compound for studying the mechanisms of viral replication and the development of novel antiviral therapies. Its broad-spectrum activity against multiple RNA viruses makes it an attractive candidate for investigating potential synergistic effects with other antiviral agents and for understanding the underlying principles of viral resistance and adaptation.
Used in Public Health Initiatives:
Favipiravir is also utilized in public health initiatives aimed at controlling and preventing the spread of infectious diseases caused by RNA viruses. Its potential use in treating COVID-19, in particular, has made it a critical component in the global effort to combat the pandemic and protect public health. As a part of these initiatives, favipiravir may be incorporated into treatment guidelines, stockpiled for emergency use, or deployed in clinical trials to evaluate its efficacy and safety in various patient populations.

Check Digit Verification of cas no

The CAS Registry Mumber 60355-67-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,3,5 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 60355-67:
(7*6)+(6*0)+(5*3)+(4*5)+(3*5)+(2*6)+(1*7)=111
111 % 10 = 1
So 60355-67-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N4O4S/c1-20-10-5-2-14-15(9(5)12-4-13-10)11-8(18)7(17)6(3-16)19-11/h2,4,6-8,11,16-18H,3H2,1H3

60355-67-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-Pyrazolo[3,4-d]pyrimidine, 4-(methylthio)-1-.β.-D-ribofuranosyl-

1.2 Other means of identification

Product number -
Other names Pyrazolopyrimidin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60355-67-1 SDS

60355-67-1Relevant academic research and scientific papers

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 60355-67-1